An open-label pilot study suggests that intravenous brexanolone may rapidly reduce psychotic, manic, and depressive symptoms in patients with postpartum psychosis, highlighting a potential new treatment option.
Read the Latest News
Drawing on current research and clinical expertise, these articles address emerging trends, treatment considerations, and the complexities of care across the reproductive lifespan.
How should psychiatrists think about hormone therapy in perimenopause? This article explains when, why, and how to consider MHT for perimenopausal women with mood and anxiety symptoms.
Learn more about the impact of perinatal depression on child neurodevelopment, new rapid-acting treatments for PPD, and new data reshaping how we treat menopausal symptoms.
Topiramate exposure in early pregnancy is linked to higher rates of major malformations and more specifically to increased risk of oral clefts, with risk rising at higher doses.
Sign up for our newsletter
Get the latest news in women’s mental health and our research.
"*" indicates required fields
